Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Control

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Insulin Pump PaQ® Enabling Glycemic Control without Daily Insulin Injections for People with Type 2 Diabetes Approved in Europe Posted: Monday, December 03, 2012

CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ® Insulin Delivery Device has received CE Mark approval.

New Treatment Reduces Weight 10 Percent and Improves Insulin Sensitivity Posted: Sunday, December 02, 2012

A new, lab-created antibody that mimics the action of a naturally occurring molecule causes weight loss.

First Possible Non-Invasive Continuous Glucose Monitor Approved in Europe Posted: Saturday, November 10, 2012

C8 MediSensors, Inc. has received Europe's CE Mark approval for its Optical Non-Invasive CGM System.

Reducing HbA1c Less than 1 Point Reduces Risk of Dying within 5 Years by 50 Percent Posted: Monday, October 29, 2012

Patients who had suboptimal glycemic control and reduced their HbA1c value by slightly less than 1% were 50% less likely to die within 5 years than were patients whose HbA1c did not improve.

Regular Glucose Monitoring Increases Medication Adherence and Reduces A1c Posted: Sunday, October 28, 2012

Blood glucose monitoring at least once a day is associated with reduced A1C levels and greater adherence to medication in type 2 diabetes patients who do not take insulin.

EASD: New EASD/ADA Position Paper Shifts Treatment Goals with 7 Key Points Posted: Tuesday, October 09, 2012

A new position statement for treatment of type 2 diabetes treatment focuses on the individual patient rather than a "one number fits all" HbA1c target.

EASD: Merck's Investigational Once-Weekly DPP-4 Inhibitor Significantly Lowered Blood Sugar in Patients with Type 2 Diabetes Posted: Monday, October 08, 2012

Merck announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.

L-cysteine a Possible Therapy for Type-2 Diabetes Posted: Tuesday, October 02, 2012

Taking L-cysteine supplements may help patients with type 2 diabetes better control blood sugar levels.

Corn Helps Type 2 Diabetes, Kidney Complications Posted: Tuesday, September 25, 2012

A purple corn variety found in Chile and Peru has been shown to possess some antidiabetic properties that may prove helpful in type 2 diabetes and associated kidney complications.

Fructose Consumption Impairs Insulin Sensitivity Posted: Tuesday, September 18, 2012

Fructose and sucrose worsen lipid profiles compared with similar amount of glucose.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.